Literature DB >> 27252363

Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins.

Ian B Robertson1, Daniel B Rifkin2.   

Abstract

The bioavailability of members of the transforming growth factor β (TGF-β) family is controlled by a number of mechanisms. Bona fide TGF-β is sequestered into the matrix in a latent state and must be activated before it can bind to its receptors. Here, we review the molecules and mechanisms that regulate the bioavailability of TGF-β and compare these mechanisms with those used to regulate other TGF-β family members. We also assess the physiological significance of various latent TGF-β activators, as well as other extracellular modulators of TGF-β family signaling, by examining the available in vivo data from knockout mouse models and other biological systems.
Copyright © 2016 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27252363      PMCID: PMC4888822          DOI: 10.1101/cshperspect.a021907

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  209 in total

1.  The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta.

Authors:  S M Ribeiro; M Poczatek; S Schultz-Cherry; M Villain; J E Murphy-Ullrich
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

2.  Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.

Authors:  Q Yu; I Stamenkovic
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

Review 3.  Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology.

Authors:  J E Murphy-Ullrich; M Poczatek
Journal:  Cytokine Growth Factor Rev       Date:  2000 Mar-Jun       Impact factor: 7.638

Review 4.  Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action.

Authors:  J Saharinen; M Hyytiäinen; J Taipale; J Keski-Oja
Journal:  Cytokine Growth Factor Rev       Date:  1999-06       Impact factor: 7.638

5.  Activation of platelet-transforming growth factor beta-1 in the absence of thrombospondin-1.

Authors:  M Abdelouahed; A Ludlow; G Brunner; J Lawler
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

6.  Thrombospondin 1 does not activate transforming growth factor beta1 in a chemically defined system or in smooth-muscle-cell cultures.

Authors:  D J Grainger; E K Frow
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

Review 7.  Latency and activation in the control of TGF-beta.

Authors:  M H Barcellos-Hoff
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-10       Impact factor: 2.673

8.  Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36.

Authors:  T Yehualaeshet; R O'Connor; J Green-Johnson; S Mai; R Silverstein; J E Murphy-Ullrich; N Khalil
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

9.  The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis.

Authors:  J S Munger; X Huang; H Kawakatsu; M J Griffiths; S L Dalton; J Wu; J F Pittet; N Kaminski; C Garat; M A Matthay; D B Rifkin; D Sheppard
Journal:  Cell       Date:  1999-02-05       Impact factor: 41.582

10.  MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover.

Authors:  K Holmbeck; P Bianco; J Caterina; S Yamada; M Kromer; S A Kuznetsov; M Mankani; P G Robey; A R Poole; I Pidoux; J M Ward; H Birkedal-Hansen
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

View more
  118 in total

Review 1.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

Review 2.  Specificity, versatility, and control of TGF-β family signaling.

Authors:  Rik Derynck; Erine H Budi
Journal:  Sci Signal       Date:  2019-02-26       Impact factor: 8.192

Review 3.  TGF-β Family Signaling in Connective Tissue and Skeletal Diseases.

Authors:  Elena Gallo MacFarlane; Julia Haupt; Harry C Dietz; Eileen M Shore
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-11-01       Impact factor: 10.005

Review 4.  Immunoregulation by members of the TGFβ superfamily.

Authors:  WanJun Chen; Peter Ten Dijke
Journal:  Nat Rev Immunol       Date:  2016-11-25       Impact factor: 53.106

5.  Lineage-specific events underlie aortic root aneurysm pathogenesis in Loeys-Dietz syndrome.

Authors:  Elena Gallo MacFarlane; Sarah J Parker; Joseph Y Shin; Benjamin E Kang; Shira G Ziegler; Tyler J Creamer; Rustam Bagirzadeh; Djahida Bedja; Yichun Chen; Juan F Calderon; Katherine Weissler; Pamela A Frischmeyer-Guerrerio; Mark E Lindsay; Jennifer P Habashi; Harry C Dietz
Journal:  J Clin Invest       Date:  2019-01-07       Impact factor: 14.808

Review 6.  The role of transforming growth factor (TGF)-β in the infarcted myocardium.

Authors:  Nikolaos G Frangogiannis
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 7.  Mechanistic insight into contextual TGF-β signaling.

Authors:  Ying E Zhang
Journal:  Curr Opin Cell Biol       Date:  2017-11-14       Impact factor: 8.382

8.  Effects of Increased Arterial Stiffness on Atherosclerotic Plaque Amounts.

Authors:  Kellie V Stoka; Justine A Maedeker; Lisa Bennett; Siddharth A Bhayani; William S Gardner; Jesse D Procknow; Austin J Cocciolone; Tezin A Walji; Clarissa S Craft; Jessica E Wagenseil
Journal:  J Biomech Eng       Date:  2018-05-01       Impact factor: 2.097

Review 9.  TGF-β1 Signaling and Tissue Fibrosis.

Authors:  Kevin K Kim; Dean Sheppard; Harold A Chapman
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

10.  A Milieu Molecule for TGF-β Required for Microglia Function in the Nervous System.

Authors:  Yan Qin; Brian S Garrison; Wenjiang Ma; Rui Wang; Aiping Jiang; Jing Li; Meeta Mistry; Roderick T Bronson; Daria Santoro; Charlotte Franco; Daisy A Robinton; Beth Stevens; Derrick J Rossi; Chafen Lu; Timothy A Springer
Journal:  Cell       Date:  2018-06-14       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.